Gene · 2073
Papers2,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From silence to symphony: transcriptional repression and recovery in response to DNA damage. | Transcription | 2024 | 39353089 | PubTator, text mining | PubMed |
| Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based Studies. | Cancers (Basel) | 2024 | 39335146 | PubTator, text mining | PubMed |
| Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma. | BMC Cancer | 2024 | 39237917 | PubTator, text mining | PubMed |
| Drug-Target Interactions Prediction at Scale: The Komet Algorithm with the LCIdb Dataset. | J Chem Inf Model | 2024 | 39237105 | PubTator, text mining | PubMed |
| From rest to repair: Safeguarding genomic integrity in quiescent cells. | DNA Repair (Amst) | 2024 | 39167890 | PubTator, text mining | PubMed |
| Prognostic Model and Immune Response of Clear Cell Renal Cell Carcinoma Based on Co-Expression Genes Signature. | Clin Genitourin Cancer | 2024 | 39129082 | PubTator, text mining | PubMed |
| Does the XPA-FEN1 Interaction Concern to Nucleotide Excision Repair or Beyond? | Biomolecules | 2024 | 39062528 | PubTator, text mining | PubMed |
| Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study. | Chin J Cancer Res | 2024 | 38988482 | PubTator, text mining | PubMed |
| Adult-Onset Neuropsychiatric Symptoms as the Presenting Feature of Xeroderma Pigmentosum Group G: A Report of a Rare Case. | Cureus | 2024 | 38975443 | PubTator, text mining | PubMed |
| Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women. | Breast Cancer Res Treat | 2024 | 38969945 | PubTator, text mining | PubMed |
| XPD stalled on cross-linked DNA provides insight into damage verification. | Nat Struct Mol Biol | 2024 | 38806694 | PubTator, text mining | PubMed |
| To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment. | Front Immunol | 2024 | 38726002 | PubTator, text mining | PubMed |
| Metabolomic analysis of dietary-restriction-induced attenuation of sarcopenia in prematurely aging DNA repair-deficient mice. | J Cachexia Sarcopenia Muscle | 2024 | 38689513 | PubTator, text mining | PubMed |
| Persistent TFIIH binding to non-excised DNA damage causes cell and developmental failure. | Nat Commun | 2024 | 38664429 | PubTator, text mining | PubMed |
| The Role of DNA Repair (XPC, XPD, XPF, and XPG) Gene Polymorphisms in the Development of Myeloproliferative Neoplasms. | Medicina (Kaunas) | 2024 | 38541232 | PubTator, text mining | PubMed |
| Relationship between XPA, XPB/ERCC3, XPF/ERCC4, and XPG/ERCC5 Polymorphisms and the Susceptibility to Head and Neck Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. | Medicina (Kaunas) | 2024 | 38541204 | PubTator, text mining | PubMed |
| Human NTHL1 expression and subcellular distribution determines cisplatin sensitivity in human lung epithelial and non-small cell lung cancer cells. | NAR Cancer | 2024 | 38384388 | PubTator, text mining | PubMed |
| Noise Stress Abrogates Structure-Specific Endonucleases within the Mammalian Inner Ear. | Int J Mol Sci | 2024 | 38339024 | PubTator, text mining | PubMed |
| Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra. | Asian Pac J Cancer Prev | 2024 | 38285784 | PubTator, text mining | PubMed |
| ERCC1 abundance is an indicator of DNA repair-apoptosis decision upon DNA damage. | Cell Death Discov | 2024 | 38272916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2073/papers?page=4